Eric Edwards, MD, PhDCo Founder

United States - Richmond, Virginia

Think beyond success. Impact people’s lives in a significant way; believe big and follow through. That is my life story.

Over the last several decades, U.S.-based manufacturing capabilities for essential medicines have been critically compromised due to the globalization of the pharmaceutical industry. I co-founded Phlow Corporation to help change that. Today, we’re securing our nation’s supply of essential drugs by bringing end-to-end manufacturing of these medicines back to the US.

I have always been a problem solver. All our lives, my twin brother, Evan, and I have had life-threatening food allergies. We founded kaléo® Inc., a pharmaceutical company with a mission to invent, manufacture and commercialize life-transforming products that empower patients and families to live fuller, bolder lives. As teenagers, we invented Auvi-Q®, the leading competitor to the EpiPen®. It is a product small enough to fit in a pocket, operates using voice instructions to guide users through the injection process, and the only epinephrine auto-injector with an auto-retractable needle and a dose designed specifically for infants. Along the way, we learned that there are many areas of the pharmaceutical industry that are in dire need of innovation.

This desire to innovate sparked a passion in me to develop other solutions for the pharmaceutical industry. I am excited and proud that Phlow and our partners Civica RX, AMPAC and VCU’s Medicine for All Institute will be working to reverse the essential drug shortage in this nation. Our collective vision is to make the U.S. a country where every person has access to the essential medicines necessary to sustain life and conquer disease.

Learn more at phlow-usa.com.